Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Longsha Liu; Thijs A van Schaik; Kok-Siong Chen; Filippo Rossignoli; Paulo Borges; Vladimir Vrbanac; Hiroaki Wakimoto; Khalid Shah

doi:10.3389/fimmu.2024.1466387

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Front Immunol. 2024 Aug 5:15:1466387. doi: 10.3389/fimmu.2024.1466387. eCollection 2024.

Authors

Longsha Liu^{1

2}, Thijs A van Schaik^{1

2}, Kok-Siong Chen^{1

2}, Filippo Rossignoli^{1

2}, Paulo Borges^{1

2}, Vladimir Vrbanac³, Hiroaki Wakimoto^{1

2

4}, Khalid Shah^{1

2

5}

Affiliations

¹ Center for Stem Cell and Translational Immunotherapy (CSTI), Harvard Medical School, Boston, MA, United States.
² Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
³ Humanized Immune System Mouse Program, Ragon Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
⁴ Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
⁵ Harvard Stem Cell Institute, Harvard University, Cambridge, MA, United States.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1324618.].

Keywords: BLT humanized mice; GBM - multiforme; flow cytometry; hGBM; humanized mice; multiplex immunofluorescence staining.

Publication types

Published Erratum